Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 7
1973 15
1974 5
1975 11
1976 13
1977 8
1978 5
1979 10
1980 21
1981 10
1982 12
1983 15
1984 18
1985 13
1986 13
1987 25
1988 29
1989 19
1990 26
1991 28
1992 25
1993 34
1994 30
1995 25
1996 30
1997 35
1998 21
1999 30
2000 25
2001 21
2002 20
2003 34
2004 23
2005 32
2006 31
2007 31
2008 31
2009 31
2010 36
2011 46
2012 58
2013 56
2014 51
2015 44
2016 40
2017 35
2018 32
2019 30
2020 30
2021 36
2022 38
2023 24
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,280 results

Results by year

Filters applied: . Clear all
Page 1
Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.
Li JH, Brenner LN, Kaur V, Figueroa K, Schroeder P, Huerta-Chagoya A; MAGIC Investigators; Diabetes Prevention Program (DPP) Research Group; Udler MS, Leong A, Mercader JM, Florez JC. Li JH, et al. Diabetologia. 2023 Jul;66(7):1260-1272. doi: 10.1007/s00125-023-05922-7. Epub 2023 May 26. Diabetologia. 2023. PMID: 37233759 Free PMC article.
The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) examined the acute response to metformin and glipizide in order to identify new pharmacogenetic associations for the response to common glucose-lowering medic …
The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) examined the acute respon …
[Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
Zhang ZH, Wang Y, Wu WF, Zhao X, Sun XC, Wang HQ. Zhang ZH, et al. Yao Xue Xue Bao. 2012 Dec;47(12):1687-95. Yao Xue Xue Bao. 2012. PMID: 23460977 Chinese.
Firstly, the expert system for the formulation design of osmotic pump of poor water-soluble drug was employed to design the formulation of glipizide PPOP, taking the dissolution test results of Glucotrol XL as the goal. ...The samples which were similar to Glucot …
Firstly, the expert system for the formulation design of osmotic pump of poor water-soluble drug was employed to design the formulation of …
Use of hypoglycemic drugs during lactation.
Glatstein MM, Djokanovic N, Garcia-Bournissen F, Finkelstein Y, Koren G. Glatstein MM, et al. Can Fam Physician. 2009 Apr;55(4):371-3. Can Fam Physician. 2009. PMID: 19366943 Free PMC article. Review.
QUESTION: My patient was taking glipizide (an oral sulfonylurea) for type 2 diabetes. Now she is pregnant and taking insulin instead. ...ANSWER: The exposure of infants to second-generation sulfonylureas (eg, glipizide, glyburide) through breast milk is expected to …
QUESTION: My patient was taking glipizide (an oral sulfonylurea) for type 2 diabetes. Now she is pregnant and taking insulin instead. …
Glipizide: an overview.
Shuman CR. Shuman CR. Am J Med. 1983 Nov 30;75(5B):55-9. doi: 10.1016/0002-9343(83)90254-1. Am J Med. 1983. PMID: 6369968 Clinical Trial.
This is a brief summary of the extensive clinical experience with glipizide in the treatment of noninsulin-dependent diabetes mellitus. ...
This is a brief summary of the extensive clinical experience with glipizide in the treatment of noninsulin-dependent diabetes mellitu …
Blinding controlled-release tablets for clinical trials.
Felton LA, Wiley CJ. Felton LA, et al. Drug Dev Ind Pharm. 2003 Jan;29(1):9-18. doi: 10.1081/ddc-120016679. Drug Dev Ind Pharm. 2003. PMID: 12602488
To test the applicability of this overcoating technique for blinding other controlled release products, the same procedure was used to coat Glucotrol XL 5 mg tablets and Theo-Dur 200 mg tablets. The debossing on the Theo-Dur tablets and the laser-drilled hole on the surfac …
To test the applicability of this overcoating technique for blinding other controlled release products, the same procedure was used to coat …
Compression-coated tablets of glipizide using hydroxypropylcellulose for zero-order release: in vitro and in vivo evaluation.
Huang H, Wu Z, Qi X, Zhang H, Chen Q, Xing J, Chen H, Rui Y. Huang H, et al. Int J Pharm. 2013 Mar 25;446(1-2):211-8. doi: 10.1016/j.ijpharm.2013.01.039. Epub 2013 Jan 28. Int J Pharm. 2013. PMID: 23370433
The purpose of this study was to design a zero-order release of compression-coated tablets using hydroxypropylcellulose (HPC) as the coating layer and glipizide which was solubilized by manufacturing the inclusion complex of beta-cyclodextrin as a model drug. The effects o …
The purpose of this study was to design a zero-order release of compression-coated tablets using hydroxypropylcellulose (HPC) as the coating …
Glipizide: an oral hypoglycemic drug.
Wensing G. Wensing G. Am J Med Sci. 1989 Jul;298(1):69-71. doi: 10.1097/00000441-198907000-00012. Am J Med Sci. 1989. PMID: 2665487 Review. No abstract available.
Development of controlled release osmotic pump tablet of glipizide solid dispersion.
Patel GC, Asodaria KV, Patel HP, Shah DR. Patel GC, et al. Curr Drug Deliv. 2014;11(6):817-27. doi: 10.2174/15672018113109990040. Curr Drug Deliv. 2014. PMID: 23859357
In-vitro drug release profiles of COPT tablets were compared with marketed with push-pull osmotic pump tablet, Glucotrol XL. RESULTS: Prepared core and coated tablets showed acceptable pharmacotechnical parameters. ...Zero order drug release pattern was achieved which was …
In-vitro drug release profiles of COPT tablets were compared with marketed with push-pull osmotic pump tablet, Glucotrol XL. RESULTS: …
Hypoglycemia treatment.
Slover-Zipf J. Slover-Zipf J. Am J Nurs. 1999 Oct;99(10):14. Am J Nurs. 1999. PMID: 10542837 No abstract available.
Glipizide Alleviates Periodontitis Pathogenicity via Inhibition of Angiogenesis, Osteoclastogenesis and M1/M2 Macrophage Ratio in Periodontal Tissue.
Guo X, Huang Z, Ge Q, Yang L, Liang D, Huang Y, Jiang Y, Pathak JL, Wang L, Ge L. Guo X, et al. Inflammation. 2023 Oct;46(5):1917-1931. doi: 10.1007/s10753-023-01850-1. Epub 2023 Jun 8. Inflammation. 2023. PMID: 37289398
Glipizide significantly inhibited osteoclast differentiation in vitro experiments. Glipizide treatment did not affect the oral microbiome of periodontitis mice. mRNA sequencing and KEGG analysis showed that glipizide activated PI3K/AKT signaling in LPS-stimul …
Glipizide significantly inhibited osteoclast differentiation in vitro experiments. Glipizide treatment did not affect the oral …
1,280 results